Co-founder, Magali brings over 20 years of experience in rare disease genetics, particularly cystic fibrosis. A recognized scientist with a PhD in Toxicogenomics and author of 33 scientific publications, her career combines academic research, clinical collaboration, and expertise in molecular diagnostics. She leads the company’s scientific vision and research strategy, dedicated to advancing innovative solutions for patients with rare diseases (Cystic Fibrosis).